Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 17Withdrawn 8Unknown 7Terminated 2Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 49INDUSTRY 13NETWORK 5NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 188Magnetic Resonance Spectroscopy 143Biopsy 116Nivolumab 39Radiation 30X-Rays 29Immunoglobulin G 29Disulfides 29Carboplatin 28Paclitaxel 26atezolizumab 25Taxes 25pembrolizumab 24Radiotherapy 24Cyclophosphamide 24Ipilimumab 23CTLA-4 Antigen 23olaparib 22Doxorubicin 22Cisplatin 22Platinum 211,2-diaminocyclohexaneplatinum II citrate 21Gemcitabine 20Bevacizumab 20Vincristine 19Phantoms, Imaging 19trametinib 16Cytarabine 16cabozantinib 15Rituximab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × NIH × Drug Therapy × Clear all
NCT02392429 2026-04-13

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
87 enrolled 15 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡